Meredith Manning, Chief Commercial Officer: Soleno Therapeutics SLNO Sell · Filed 03/31

Trade details

Type: Insider sale
Amount: $65,184
Shares · price: 2,100 sh · $31.04 a share
Held after: 65,065 sh
Stock: Soleno Therapeutics SLNO
Person: Meredith ManningChief Commercial Officer
Trade date: 26/03/27
Filed: 26/03/31
Days to filing: 4 days

Sold 3.1% of holdings

Share of holding sold: 3.1%

Soleno Therapeutics trades, last 26 weeks

What else happened in Soleno Therapeutics around then

Filed or reported within 30 days of the trade day · 02/25~04/26

Meredith Manning's recent trades

Meredith ManningChief Commercial Officer
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$146.1K
4,864 sh
$146.1K
Filed 03/31
Traded 03/27
Meredith ManningChief Commercial Officer
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$17.7K
558 sh
$17.7K
Filed 03/31
Traded 03/27
Meredith ManningChief Commercial Officer
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$2.5M
37,000 sh
$2.5M
Filed 25/03/31
Traded 25/03/27
Meredith ManningChief Commercial Officer
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$178.8K
2,599 sh
$178.8K
Filed 25/03/31
Traded 25/03/27
Meredith ManningChief Commercial Officer
SellSoleno Therapeutics
Sell
Soleno Therapeutics
SLNO
$133.8K
1,976 sh
$133.8K
Filed 25/03/31
Traded 25/03/27